Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Noevir Holdings Co's Accounts Payable for the quarter that ended in Dec. 2025 was 円3,230 Mil.
Noevir Holdings Co's quarterly Accounts Payable
increased
from Jun. 2025 (円3,172 Mil) to Sep. 2025 (円3,240 Mil) but then
declined
from Sep. 2025 (円3,240 Mil) to Dec. 2025 (円3,230 Mil).
Noevir Holdings Co's annual Accounts Payable
increased
from Sep. 2023 (円2,903 Mil) to Sep. 2024 (円2,951 Mil) and
increased
from Sep. 2024 (円2,951 Mil) to Sep. 2025 (円3,240 Mil).
Noevir Holdings Co Accounts Payable Related Terms
Noevir Holdings Co Accounts Payable Historical Data
* Premium members only.
The historical data trend for Noevir Holdings Co's Accounts Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
Noevir Holdings Co (TSE:4928) has a Accounts Payable of 円3,230 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Noevir Holdings Co and its competitors.
Is Noevir Holdings Co's Accounts Payable too high?
Noevir Holdings Co's current Accounts Payable is 円3,230 Mil. Overall, Noevir Holdings Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's Accounts Payable compare to PG and CL?
Noevir Holdings Co's Accounts Payable of 円3,230 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Consumer Packaged Goods company?
A good Accounts Payable depends on the Consumer Packaged Goods industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Noevir Holdings Co and its competitors. Noevir Holdings Co's current Accounts Payable is 円3,230 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Fairly Valued. The stock's GF Value™ is 円5,267.59, compared to a current price of 円4,955.00 — trading 5.9% below its estimated fair value. The current Accounts Payable is 円3,230 Mil. Noevir Holdings Co's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current Accounts Payable is 円3,230 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?
Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued.
The current stock price of 円4,955.00 is trading 5.9% below its estimated GF Value™ of 円5,267.59.
GuruFocus considers Noevir Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4928:
Accounts Payable: 円3,230 Mil
GF Value™: 円5,267.59 vs. price of 円4,955.00 (5.9% below fair value)
No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
84GF Score
Get the complete analysis for TSE:4928
Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4928 has been successfully added to your 
